NEO Annual EBIT
-$90.19 M
+$61.57 M+40.57%
31 December 2023
Summary:
As of January 21, 2025, NEO annual earnings before interest & taxes is -$90.19 million, with the most recent change of +$61.57 million (+40.57%) on December 31, 2023. During the last 3 years, it has fallen by -$83.15 million (-1181.65%). NEO annual EBIT is now -997.06% below its all-time high of $46.50 million.NEO EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NEO Quarterly EBIT
-$16.21 M
+$1.14 M+6.59%
30 September 2024
Summary:
As of January 21, 2025, NEO quarterly earnings before interest & taxes is -$16.21 million, with the most recent change of +$1.14 million (+6.59%) on September 30, 2024. Over the past year, it has dropped by -$2.60 million (-19.13%). NEO quarterly EBIT is now -266.04% below its all-time high of $9.76 million, reached on December 31, 2020.NEO Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NEO TTM EBIT
-$73.16 M
+$3.56 M+4.64%
30 September 2024
Summary:
As of January 21, 2025, NEO TTM earnings before interest & taxes is -$73.16 million, with the most recent change of +$3.56 million (+4.64%) on September 30, 2024. Over the past year, it has increased by +$17.03 million (+18.88%). NEO TTM EBIT is now -772.48% below its all-time high of $10.88 million, reached on September 30, 2018.NEO TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NEO EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +40.6% | -19.1% | +18.9% |
| 3 y3 years | -1181.7% | +25.9% | -47.5% |
| 5 y5 years | -997.1% | -538.7% | -1094.3% |
NEO EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1215.7% | +40.6% | -19.1% | +68.8% | at high | +57.1% |
| 5 y | 5-year | -1325.7% | +40.6% | -266.0% | +68.8% | -1094.3% | +57.1% |
| alltime | all time | -997.1% | +40.6% | -266.0% | +68.8% | -772.5% | +57.1% |
NeoGenomics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$16.21 M(-6.6%) | -$73.16 M(-4.6%) |
| June 2024 | - | -$17.35 M(-33.3%) | -$76.72 M(-8.9%) |
| Mar 2024 | - | -$26.00 M(+91.1%) | -$84.22 M(-6.6%) |
| Dec 2023 | -$90.19 M(-40.6%) | -$13.61 M(-31.2%) | -$90.19 M(-6.9%) |
| Sept 2023 | - | -$19.77 M(-20.5%) | -$96.89 M(-16.9%) |
| June 2023 | - | -$24.86 M(-22.2%) | -$116.61 M(-11.3%) |
| Mar 2023 | - | -$31.96 M(+57.4%) | -$131.46 M(-13.2%) |
| Dec 2022 | -$151.76 M(+2113.9%) | -$20.31 M(-48.6%) | -$151.52 M(-11.2%) |
| Sept 2022 | - | -$39.48 M(-0.5%) | -$170.57 M(+11.5%) |
| June 2022 | - | -$39.70 M(-23.7%) | -$152.96 M(+12.8%) |
| Mar 2022 | - | -$52.03 M(+32.2%) | -$135.63 M(+37.4%) |
| Dec 2021 | -$6.86 M(-2.6%) | -$39.36 M(+79.9%) | -$98.71 M(+99.1%) |
| Sept 2021 | - | -$21.87 M(-2.2%) | -$49.59 M(+115.3%) |
| June 2021 | - | -$22.37 M(+48.1%) | -$23.03 M(+34.9%) |
| Mar 2021 | - | -$15.11 M(-254.8%) | -$17.07 M(+142.6%) |
| Dec 2020 | -$7.04 M(-195.6%) | $9.76 M(+108.6%) | -$7.04 M(-49.7%) |
| Sept 2020 | - | $4.68 M(-128.5%) | -$13.98 M(-6.6%) |
| June 2020 | - | -$16.41 M(+223.6%) | -$14.97 M(-404.9%) |
| Mar 2020 | - | -$5.07 M(-280.1%) | $4.91 M(-33.3%) |
| Dec 2019 | $7.36 M(-26.8%) | $2.81 M(-23.8%) | $7.36 M(-0.7%) |
| Sept 2019 | - | $3.69 M(+6.5%) | $7.41 M(-3.3%) |
| June 2019 | - | $3.47 M(-232.4%) | $7.67 M(+57.6%) |
| Mar 2019 | - | -$2.62 M(-191.5%) | $4.87 M(-51.6%) |
| Dec 2018 | $10.05 M(+247.9%) | $2.87 M(-27.4%) | $10.05 M(-7.6%) |
| Sept 2018 | - | $3.95 M(+489.6%) | $10.88 M(+123.6%) |
| June 2018 | - | $670.00 K(-73.9%) | $4.87 M(-19.4%) |
| Mar 2018 | - | $2.57 M(-30.4%) | $6.04 M(+109.0%) |
| Dec 2017 | $2.89 M(+34.1%) | $3.69 M(-278.8%) | $2.89 M(-169.5%) |
| Sept 2017 | - | -$2.06 M(-212.1%) | -$4.16 M(+495.6%) |
| June 2017 | - | $1.84 M(-417.4%) | -$698.00 K(+101.7%) |
| Mar 2017 | - | -$580.00 K(-82.7%) | -$346.00 K(-116.0%) |
| Dec 2016 | $2.15 M(-159.3%) | -$3.35 M(-340.4%) | $2.16 M(-6.0%) |
| Sept 2016 | - | $1.40 M(-36.4%) | $2.29 M(+126.5%) |
| June 2016 | - | $2.19 M(+14.1%) | $1.01 M(-187.9%) |
| Mar 2016 | - | $1.92 M(-159.8%) | -$1.15 M(-68.3%) |
| Dec 2015 | -$3.63 M(-259.9%) | -$3.22 M(-2921.1%) | -$3.63 M(-480.2%) |
| Sept 2015 | - | $114.00 K(+307.1%) | $956.00 K(+24.3%) |
| June 2015 | - | $28.00 K(-105.0%) | $769.00 K(-41.7%) |
| Mar 2015 | - | -$561.00 K(-140.8%) | $1.32 M(-42.0%) |
| Dec 2014 | $2.27 M(-28.4%) | $1.38 M(-1983.6%) | $2.27 M(+8.2%) |
| Sept 2014 | - | -$73.00 K(-112.6%) | $2.10 M(-37.0%) |
| June 2014 | - | $578.00 K(+46.7%) | $3.33 M(+2.2%) |
| Mar 2014 | - | $394.00 K(-67.2%) | $3.26 M(+2.8%) |
| Dec 2013 | $3.17 M(+162.1%) | $1.20 M(+3.7%) | $3.17 M(+46.5%) |
| Sept 2013 | - | $1.16 M(+129.7%) | $2.17 M(+572.7%) |
| June 2013 | - | $505.00 K(+65.6%) | $322.00 K(-50.9%) |
| Mar 2013 | - | $305.00 K(+55.6%) | $656.00 K(-45.9%) |
| Dec 2012 | $1.21 M | $196.00 K(-128.7%) | $1.21 M(-12.9%) |
| Sept 2012 | - | -$684.00 K(-181.5%) | $1.39 M(-34.3%) |
| June 2012 | - | $839.00 K(-2.6%) | $2.12 M(+81.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | $861.00 K(+129.6%) | $1.16 M(-385.3%) |
| Dec 2011 | -$409.00 K(-86.2%) | $375.00 K(+792.9%) | -$408.00 K(-69.7%) |
| Sept 2011 | - | $42.00 K(-136.8%) | -$1.35 M(-43.9%) |
| June 2011 | - | -$114.00 K(-84.0%) | -$2.40 M(-22.2%) |
| Mar 2011 | - | -$711.00 K(+26.3%) | -$3.08 M(+4.0%) |
| Dec 2010 | -$2.96 M(+71.5%) | -$563.00 K(-44.4%) | -$2.96 M(-21.8%) |
| Sept 2010 | - | -$1.01 M(+27.0%) | -$3.79 M(+11.3%) |
| June 2010 | - | -$797.00 K(+34.9%) | -$3.40 M(+37.9%) |
| Mar 2010 | - | -$591.00 K(-57.4%) | -$2.47 M(+42.8%) |
| Dec 2009 | -$1.73 M(+95.5%) | -$1.39 M(+121.7%) | -$1.73 M(+66.9%) |
| Sept 2009 | - | -$626.00 K(-553.6%) | -$1.04 M(+95.6%) |
| June 2009 | - | $138.00 K(-6.8%) | -$529.20 K(+0.7%) |
| Mar 2009 | - | $148.00 K(-121.3%) | -$525.70 K(-40.5%) |
| Dec 2008 | -$884.00 K(-71.9%) | -$695.10 K(+478.8%) | -$884.00 K(-49.5%) |
| Sept 2008 | - | -$120.10 K(-184.9%) | -$1.75 M(-20.7%) |
| June 2008 | - | $141.50 K(-167.3%) | -$2.21 M(-31.6%) |
| Mar 2008 | - | -$210.30 K(-86.5%) | -$3.23 M(-0.3%) |
| Dec 2007 | -$3.14 M(-2343.6%) | -$1.56 M(+170.8%) | -$3.24 M(+56.6%) |
| Sept 2007 | - | -$576.90 K(-34.5%) | -$2.07 M(+50.3%) |
| June 2007 | - | -$880.90 K(+301.3%) | -$1.38 M(+311.9%) |
| Mar 2007 | - | -$219.50 K(-43.9%) | -$334.10 K(-641.5%) |
| Dec 2006 | $140.00 K(-117.5%) | -$391.20 K(-439.3%) | $61.70 K(-58.4%) |
| Sept 2006 | - | $115.30 K(-28.5%) | $148.20 K(-201.9%) |
| June 2006 | - | $161.30 K(-8.5%) | -$145.40 K(-66.7%) |
| Mar 2006 | - | $176.30 K(-157.9%) | -$436.00 K(-45.5%) |
| Dec 2005 | -$800.40 K(+9.7%) | -$304.70 K(+70.9%) | -$800.30 K(+2.2%) |
| Sept 2005 | - | -$178.30 K(+37.9%) | -$782.80 K(+4.0%) |
| June 2005 | - | -$129.30 K(-31.2%) | -$752.50 K(-2.1%) |
| Mar 2005 | - | -$188.00 K(-34.5%) | -$768.70 K(+5.4%) |
| Dec 2004 | -$729.60 K(+47.6%) | -$287.20 K(+94.1%) | -$729.60 K(+27.8%) |
| Sept 2004 | - | -$148.00 K(+1.7%) | -$570.80 K(+4.1%) |
| June 2004 | - | -$145.50 K(-2.3%) | -$548.40 K(+2.9%) |
| Mar 2004 | - | -$148.90 K(+16.0%) | -$532.70 K(+7.8%) |
| Dec 2003 | -$494.30 K(-15.3%) | -$128.40 K(+2.2%) | -$494.30 K(-145.0%) |
| Sept 2003 | - | -$125.60 K(-3.2%) | $1.10 M(+122.8%) |
| June 2003 | - | -$129.80 K(+17.5%) | $493.40 K(+20.8%) |
| Mar 2003 | - | -$110.50 K(-107.5%) | $408.60 K(-762.2%) |
| Dec 2002 | -$583.70 K(-92.8%) | $1.47 M(-300.3%) | -$61.70 K(-97.5%) |
| Sept 2002 | - | -$731.30 K(+240.8%) | -$2.45 M(+42.6%) |
| June 2002 | - | -$214.60 K(-63.1%) | -$1.72 M(0.0%) |
| Mar 2002 | - | -$580.80 K(-37.1%) | -$1.72 M(+15.9%) |
| Dec 2001 | -$8.08 M(+732.0%) | -$923.80 K(<-9900.0%) | -$1.48 M(+47.6%) |
| Sept 2001 | - | $800.00(-100.4%) | -$1.00 M(-12.5%) |
| June 2001 | - | -$214.60 K(-37.8%) | -$1.15 M(-0.2%) |
| Mar 2001 | - | -$344.80 K(-22.6%) | -$1.15 M(+18.4%) |
| Dec 2000 | -$970.90 K | -$445.40 K(+213.0%) | -$971.00 K(+84.7%) |
| Sept 2000 | - | -$142.30 K(-34.4%) | -$525.60 K(+37.1%) |
| June 2000 | - | -$217.00 K(+30.5%) | -$383.30 K(+130.5%) |
| Mar 2000 | - | -$166.30 K(+68.0%) | -$166.30 K(+68.0%) |
| Mar 1999 | - | -$99.00 K | -$99.00 K |
FAQ
- What is NeoGenomics annual earnings before interest & taxes?
- What is the all time high annual EBIT for NeoGenomics?
- What is NeoGenomics annual EBIT year-on-year change?
- What is NeoGenomics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for NeoGenomics?
- What is NeoGenomics quarterly EBIT year-on-year change?
- What is NeoGenomics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for NeoGenomics?
- What is NeoGenomics TTM EBIT year-on-year change?
What is NeoGenomics annual earnings before interest & taxes?
The current annual EBIT of NEO is -$90.19 M
What is the all time high annual EBIT for NeoGenomics?
NeoGenomics all-time high annual earnings before interest & taxes is $46.50 M
What is NeoGenomics annual EBIT year-on-year change?
Over the past year, NEO annual earnings before interest & taxes has changed by +$61.57 M (+40.57%)
What is NeoGenomics quarterly earnings before interest & taxes?
The current quarterly EBIT of NEO is -$16.21 M
What is the all time high quarterly EBIT for NeoGenomics?
NeoGenomics all-time high quarterly earnings before interest & taxes is $9.76 M
What is NeoGenomics quarterly EBIT year-on-year change?
Over the past year, NEO quarterly earnings before interest & taxes has changed by -$2.60 M (-19.13%)
What is NeoGenomics TTM earnings before interest & taxes?
The current TTM EBIT of NEO is -$73.16 M
What is the all time high TTM EBIT for NeoGenomics?
NeoGenomics all-time high TTM earnings before interest & taxes is $10.88 M
What is NeoGenomics TTM EBIT year-on-year change?
Over the past year, NEO TTM earnings before interest & taxes has changed by +$17.03 M (+18.88%)